Nr4a1 (Nur77) mediates thyrotropin-releasing hormone-induced stimulation of transcription of the thyrotropin β gene: Analysis of TRH knockout mice

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Nakajima, Yasuyo ^a   Yamada, Masanobu ^a   Taguchi, Ryo ^a   Shibusawa, Nobuyuki ^a   Ozawa, Atsushi ^a   Tomaru, Takuya ^a   Hashimoto, Koshi ^a   Saito, Tsugumichi ^a   Tsuchiya, Takafumi ^a   Okada, Shuichi ^a   Satoh, Tetsurou ^a   Mori, Masatomo ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; NUCLEAR RECEPTOR NUR77; PROTIRELIN; SMALL INTERFERING RNA; THYROID HORMONE; THYROTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE; GENE EXPRESSION; GENE FUNCTION; HORMONAL REGULATION; HORMONE RELEASE; HORMONE SYNTHESIS; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NR4A1 GENE; PROMOTER REGION; THYROID HORMONE BLOOD LEVEL; THYROTROPIN BLOOD LEVEL; TSH SECRETING CELL; TSHBETA GENE; WESTERN BLOTTING;

ANIMALS; BINDING SITES; CELL LINE; CLUSTER ANALYSIS; GENE KNOCKDOWN TECHNIQUES; GENES, IMMEDIATE-EARLY; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PITUITARY GLAND; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; PROTEIN KINASE C; RATS; RECEPTORS, THYROTROPIN-RELEASING HORMONE; RNA, SMALL INTERFERING; THYROTROPHS; THYROTROPIN, BETA SUBUNIT; THYROTROPIN-RELEASING HORMONE; TRANSCRIPTIONAL ACTIVATION; TRANSCRIPTOME;

MUS;

EID: 84863612644     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040437     Document Type: Article

References (80)

1. Boler J, Enzmann F, Folkers K, Bowers C, Schally A, (1969) The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidyl-proline amide. Biochem Biophys Res Commun 37: 705-710.
2. Burgus R, Dunn T, Ward D, Vale W, Amoss M, et al. (1969) [Synthetic polypeptide derivatives with thyrotropin releasing factor hypophysiotropic activity]. C R Acad Sci Hebd Seances Acad Sci D 268: 2116-2118.
3. Jackson I, (1982) Thyrotropin-releasing hormone. N Engl J Med 306: 145-155.
4. Carr F, Shupnik M, Burnside J, Chin W, (1989) Thyrotropin-releasing hormone stimulates the activity of the rat thyrotropin beta-subunit gene promoter transfected into pituitary cells. Mol Endocrinol 3: 717-724.
5. Carr F, Fisher C, Fein H, Smallridge R, (1993) Thyrotropin-releasing hormone stimulates c-jun and c-fos messenger ribonucleic acid levels: implications for calcium mobilization and protein kinase-C activation. Endocrinology 133: 1700-1707.
6. Gershengorn M, (1989) Mechanism of signal transduction by TRH. Ann N Y Acad Sci 553: 191-196.
7. Hsieh K, Martin T, (1992) Thyrotropin-releasing hormone and gonadotropin-releasing hormone receptors activate phospholipase C by coupling to the guanosine triphosphate-binding proteins Gq and G11. Mol Endocrinol 6: 1673-1681.
8. Kiley SC, Parker PJ, Fabbro D, Jaken S, (1991) Differential regulation of protein kinase C isozymes by thyrotropin-releasing hormone in GH4C1 cells. J Biol Chem 266: 23761-23768.
9. Kanda Y, Koike K, Ohmichi M, Sawada T, Hirota K, et al. (1994) A possible involvement of tyrosine kinase in TRH-induced prolactin secretion in GH3 cells. Biochem Biophys Res Commun 199: 1447-1452.
10. Ohmichi M, Sawada T, Kanda Y, Koike K, Hirota K, et al. (1994) Thyrotropin-releasing hormone stimulates MAP kinase activity in GH3 cells by divergent pathways. Evidence of a role for early tyrosine phosphorylation. J Biol Chem 269: 3783-3788.
11. Shupnik M, Ridgway E, Chin W, (1989) Molecular biology of thyrotropin. Endocr Rev 10: 459-475.
12. Sun Y, Lu X, Gershengorn M, (2003) Thyrotropin-releasing hormone receptors - similarities and differences. J Mol Endocrinol 30: 87-97.
13. Andersen B, Rosenfeld MG, (1994) Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. J Biol Chem 269: 29335-29338.
14. Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, et al. (1992) Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1: 56-58.
15. Cohen LE, Radovick S, (2002) Molecular basis of combined pituitary hormone deficiencies. Endocr Rev 23: 431-442.
16. Steinfelder H, Radovick S, Wondisford F, (1992) Hormonal regulation of the thyrotropin beta-subunit gene by phosphorylation of the pituitary-specific transcription factor Pit-1. Proc Natl Acad Sci U S A 89: 5942-5945.
17. Gordon D, Lewis S, Haugen B, James R, McDermott M, et al. (1997) Pit-1 and GATA-2 interact and functionally cooperate to activate the thyrotropin beta-subunit promoter. J Biol Chem 272: 24339-24347.
18. Ko LJ, Engel JD, (1993) DNA-binding specificities of the GATA transcription factor family. Mol Cell Biol 13: 4011-4022.
19. Dasen JS, O'Connell SM, Flynn SE, Treier M, Gleiberman AS, et al. (1999) Reciprocal interactions of Pit1 and GATA2 mediate signaling gradient-induced determination of pituitary cell types. Cell 97: 587-598.
20. Ohba K, Sasaki S, Matsushita A, Iwaki H, Matsunaga H, et al. (2011) GATA2 mediates thyrotropin-releasing hormone-induced transcriptional activation of the thyrotropin β gene. PLoS One 6: e18667.
21. Yamada M, Saga Y, Shibusawa N, Hirato J, Murakami M, et al. (1997) Tertiary hypothyroidism and hyperglycemia in mice with targeted disruption of the thyrotropin-releasing hormone gene. Proc Natl Acad Sci U S A 94: 10862-10867.
22. Shibusawa N, Yamada M, Hirato J, Monden T, Satoh T, et al. (2000) Requirement of thyrotropin-releasing hormone for the postnatal functions of pituitary thyrotrophs: ontogeny study of congenital tertiary hypothyroidism in mice. Mol Endocrinol 14: 137-146.
23. Milbrandt J, (1988) Nerve growth factor induces a gene homologous to the glucocorticoid receptor gene. Neuron 1: 183-188.
24. Martínez-González J, Badimon L, (2005) The NR4A subfamily of nuclear receptors: new early genes regulated by growth factors in vascular cells. Cardiovasc Res 65: 609-618.
25. Fu Y, Luo L, Luo N, Zhu X, Garvey W, (2007) NR4A orphan nuclear receptors modulate insulin action and the glucose transport system: potential role in insulin resistance. J Biol Chem 282: 31525-31533.
26. Woronicz J, Calnan B, Ngo V, Winoto A, (1994) Requirement for the orphan steroid receptor Nur77 in apoptosis of T-cell hybridomas. Nature 367: 277-281.
27. Liu Z, Smith S, McLaughlin K, Schwartz L, Osborne B, (1994) Apoptotic signals delivered through the T-cell receptor of a T-cell hybrid require the immediate-early gene nur77. Nature 367: 281-284.
28. Stocco C, Zhong L, Sugimoto Y, Ichikawa A, Lau L, et al. (2000) Prostaglandin F2alpha-induced expression of 20alpha-hydroxysteroid dehydrogenase involves the transcription factor NUR77. J Biol Chem 275: 37202-37211.
29. Stocco C, Lau L, Gibori G, (2002) A calcium/calmodulin-dependent activation of ERK1/2 mediates JunD phosphorylation and induction of nur77 and 20alpha-hsd genes by prostaglandin F2alpha in ovarian cells. J Biol Chem 277: 3293-3302.
30. Bassett M, White P, Rainey W, (2004) A role for the NGFI-B family in adrenal zonation and adrenocortical disease. Endocr Res 30: 567-574.
31. Song K, Park Y, Park K, Hong C, Park J, et al. (2004) The atypical orphan nuclear receptor DAX-1 interacts with orphan nuclear receptor Nur77 and represses its transactivation. Mol Endocrinol 18: 1929-1940.
32. Philips A, Lesage S, Gingras R, Maira M, Gauthier Y, et al. (1997) Novel dimeric Nur77 signaling mechanism in endocrine and lymphoid cells. Mol Cell Biol 17: 5946-5951.
33. Philips A, Maira M, Mullick A, Chamberland M, Lesage S, et al. (1997) Antagonism between Nur77 and glucocorticoid receptor for control of transcription. Mol Cell Biol 17: 5952-5959.
34. Lim S, Luo M, Koh M, Yang M, bin Abdul Kadir M, et al. (2007) Distinct mechanisms involving diverse histone deacetylases repress expression of the two gonadotropin beta-subunit genes in immature gonadotropes, and their actions are overcome by gonadotropin-releasing hormone. Mol Cell Biol 27: 4105-4120.
35. Smith A, Luk N, Newton R, Roberts D, Sturm R, et al. (2008) Melanocortin-1 receptor signaling markedly induces the expression of the NR4A nuclear receptor subgroup in melanocytic cells. J Biol Chem 283: 12564-12570.
36. Inaoka Y, Yazawa T, Uesaka M, Mizutani T, Yamada K, et al. (2008) Regulation of NGFI-B/Nur77 gene expression in the rat ovary and in leydig tumor cells MA-10. Mol Reprod Dev 75: 931-939.
37. Fernandez P, Brunel F, Jimenez M, Saez J, Cereghini S, et al. (2000) Nuclear receptors Nor1 and NGFI-B/Nur77 play similar, albeit distinct, roles in the hypothalamo-pituitary-adrenal axis. Endocrinology 141: 2392-2400.
38. Gordon DF, Haugen BR, Sarapura VD, Nelson AR, Wood WM, et al. (1993) Analysis of Pit-1 in regulating mouse TSH beta promoter activity in thyrotropes. Mol Cell Endocrinol 96: 75-84.
39. Nikrodhanond A, Ortiga-Carvalho T, Shibusawa N, Hashimoto K, Liao X, et al. (2006) Dominant role of thyrotropin-releasing hormone in the hypothalamic-pituitary-thyroid axis. J Biol Chem 281: 5000-5007.
40. Mori M, Yamada M, Kobayashi S, (1988) Role of the hypothalamic TRH in the regulation of its own receptors in rat anterior pituitaries. Neuroendocrinology 48: 153-159.
41. Zhao J, Dahle D, Zhou Y, Zhang X, Klibanski A, (2005) Hypermethylation of the promoter region is associated with the loss of MEG3 gene expression in human pituitary tumors. J Clin Endocrinol Metab 90: 2179-2186.
42. Santelli G, Califano D, Chiappetta G, Vento M, Bartoli P, et al. (1999) Thymosin beta-10 gene overexpression is a general event in human carcinogenesis. Am J Pathol 155: 799-804.
43. Takano T, Hasegawa Y, Miyauchi A, Matsuzuka F, Yoshida H, et al. (2002) Quantitative analysis of thymosin beta-10 messenger RNA in thyroid carcinomas. Jpn J Clin Oncol 32: 229-232.
44. Lee SL, Sadovsky Y, Swirnoff AH, Polish JA, Goda P, et al. (1996) Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 273: 1219-1221.
45. Liao Y, Shikapwashya ON, Shteyer E, Dieckgraefe BK, Hruz PW, et al. (2004) Delayed hepatocellular mitotic progression and impaired liver regeneration in early growth response-1-deficient mice. J Biol Chem 279: 43107-43116.
46. Topilko P, Schneider-Maunoury S, Levi G, Trembleau A, Gourdji D, et al. (1998) Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. Mol Endocrinol 12: 107-122.
47. Crawford P, Sadovsky Y, Woodson K, Lee S, Milbrandt J, (1995) Adrenocortical function and regulation of the steroid 21-hydroxylase gene in NGFI-B-deficient mice. Mol Cell Biol 15: 4331-4316.
48. Lee SL, Wesselschmidt RL, Linette GP, Kanagawa O, Russell JH, et al. (1995) Unimpaired thymic and peripheral T cell death in mice lacking the nuclear receptor NGFI-B (Nur77). Science 269: 532-535.
49. Mullican S, Zhang S, Konopleva M, Ruvolo V, Andreeff M, et al. (2007) Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia. Nat Med 13: 730-735.
50. Nakajima Y, Yamada M, Horiguchi K, Satoh T, Hashimoto K, et al. (2010) Resistance to thyroid hormone due to a novel thyroid hormone receptor mutant in a patient with hypothyroidism secondary to lingual thyroid and functional characterization of the mutant receptor. Thyroid 20: 917-926.
51. Maira M, Martens C, Philips A, Drouin J, (1999) Heterodimerization between members of the Nur subfamily of orphan nuclear receptors as a novel mechanism for gene activation. Mol Cell Biol 19: 7549-7557.
52. Gordon D, Woodmansee W, Black J, Dowding J, Bendrick-Peart J, et al. (2002) Domains of Pit-1 required for transcriptional synergy with GATA-2 on the TSH beta gene. Mol Cell Endocrinol 196: 53-66.
53. Kashiwabara Y, Sasaki S, Matsushita A, Nagayama K, Ohba K, et al. (2009) Functions of PIT1 in GATA2-dependent transactivation of the thyrotropin beta promoter. J Mol Endocrinol 42: 225-237.
54. Chiamolera M, Wondisford F, (2009) Minireview: Thyrotropin-releasing hormone and the thyroid hormone feedback mechanism. Endocrinology 150: 1091-1096.
55. Satoh T, Yamada M, Iwasaki T, Mori M, (1996) Negative regulation of the gene for the preprothyrotropin-releasing hormone from the mouse by thyroid hormone requires additional factors in conjunction with thyroid hormone receptors. J Biol Chem 271: 27919-27926.
56. Satoh T, Ishizuka T, Monden T, Shibusawa N, Hashida T, et al. (1999) Regulation of the mouse preprothyrotropin-releasing hormone gene by retinoic acid receptor. Endocrinology 140: 5004-5013.
57. Tagami T, Madison LD, Nagaya T, Jameson JL, (1997) Nuclear receptor corepressors activate rather than suppress basal transcription of genes that are negatively regulated by thyroid hormone. Mol Cell Biol 17: 2642-2648.
58. Lazar M, (2003) Thyroid hormone action: a binding contract. J Clin Invest 112: 497-499.
59. Göthe S, Wang Z, Ng L, Kindblom JM, Barros AC, et al. (1999) Mice devoid of all known thyroid hormone receptors are viable but exhibit disorders of the pituitary-thyroid axis, growth, and bone maturation. Genes Dev 13: 1329-1341.
60. Shibusawa N, Hashimoto K, Nikrodhanond AA, Liberman MC, Applebury ML, et al. (2003) Thyroid hormone action in the absence of thyroid hormone receptor DNA-binding in vivo. J Clin Invest 112: 588-597.
61. Abel ED, Boers ME, Pazos-Moura C, Moura E, Kaulbach H, et al. (1999) Divergent roles for thyroid hormone receptor beta isoforms in the endocrine axis and auditory system. J Clin Invest 104: 291-300.
62. Forrest D, Erway LC, Ng L, Altschuler R, Curran T, (1996) Thyroid hormone receptor beta is essential for development of auditory function. Nat Genet 13: 354-357.
63. Lavoie P, Budry L, Balsalobre A, Drouin J, (2008) Developmental dependence on NurRE and EboxNeuro for expression of pituitary proopiomelanocortin. Mol Endocrinol 22: 1647-1657.
64. Charles MA, Saunders TL, Wood WM, Owens K, Parlow AF, et al. (2006) Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol Endocrinol 20: 1366-1377.
65. Kelly SN, McKenna TJ, Young LS, (2005) Coregulatory protein-orphan nuclear receptor interactions in the human adrenal cortex. J Endocrinol 186: 33-42.
66. Wansa KD, Muscat GE, (2005) TRAP220 is modulated by the antineoplastic agent 6-Mercaptopurine, and mediates the activation of the NR4A subgroup of nuclear receptors. J Mol Endocrinol 34: 835-848.
67. Malovannaya A, Lanz RB, Jung SY, Bulynko Y, Le NT, et al. (2011) Analysis of the human endogenous coregulator complexome. Cell 145: 787-799.
68. Kakar S, Winters S, Zacharias W, Miller D, Flynn S, (2003) Identification of distinct gene expression profiles associated with treatment of LbetaT2 cells with gonadotropin-releasing hormone agonist using microarray analysis. Gene 308: 67-77.
69. Wurmbach E, Yuen T, Ebersole B, Sealfon S, (2001) Gonadotropin-releasing hormone receptor-coupled gene network organization. J Biol Chem 276: 47195-47201.
70. Manna P, Huhtaniemi I, Stocco D, (2009) Mechanisms of protein kinase C signaling in the modulation of 3′,5′-cyclic adenosine monophosphate-mediated steroidogenesis in mouse gonadal cells. Endocrinology 150: 3308-3317.
71. Song K, Park J, Lee M, Soh J, Lee K, et al. (2001) LH induces orphan nuclear receptor Nur77 gene expression in testicular Leydig cells. Endocrinology 142: 5116-5123.
72. Martin LJ, Boucher N, Brousseau C, Tremblay JJ, (2008) The orphan nuclear receptor NUR77 regulates hormone-induced StAR transcription in Leydig cells through cooperation with Ca2+/calmodulin-dependent protein kinase I. Mol Endocrinol 22: 2021-2037.
73. JENSEN FC, GIRARDI AJ, GILDEN RV, KOPROWSKI H, (1964) INFECTION OF HUMAN AND SIMIAN TISSUE CULTURES WITH ROUS SARCOMA VIRUS. Proc Natl Acad Sci U S A 52: 53-59.
74. Tashjian AH, Yasumura Y, Levine L, Sato GH, Parker ML, (1968) Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82: 342-352.
75. Gumbiner B, Kelly RB, (1982) Two distinct intracellular pathways transport secretory and membrane glycoproteins to the surface of pituitary tumor cells. Cell 28: 51-59.
76. Lin R, Sternsdorf T, Tini M, Evans R, (2001) Transcriptional regulation in acute promyelocytic leukemia. Oncogene 20: 7204-7215.
77. Hashimoto K, Zanger K, Hollenberg AN, Cohen LE, Radovick S, et al. (2000) cAMP response element-binding protein-binding protein mediates thyrotropin-releasing hormone signaling on thyrotropin subunit genes. J Biol Chem 275: 33365-33372.
78. Hashimoto K, Yamada M, Monden T, Satoh T, Wondisford F, et al. (2005) Thyrotropin-releasing hormone (TRH) specific interaction between amino terminus of P-Lim and CREB binding protein (CBP). Mol Cell Endocrinol 229: 11-20.
79. Umezawa R, Yamada M, Horiguchi K, Ishii S, Hashimoto K, et al. (2009) Aberrant Histone Modifications at the Thyrotropin-Releasing Hormone Gene in Resistance to Thyroid Hormone: Analysis of F455S mutant thyroid hormone receptor. Endocrinology.
80. Ishii S, Yamada M, Satoh T, Monden T, Hashimoto K, et al. (2004) Aberrant dynamics of histone deacetylation at the thyrotropin-releasing hormone gene in resistance to thyroid hormone. Mol Endocrinol 18: 1708-1720.